Human Medicines European Public Assessment Report (EPAR): Clopidogrel Ratiopharm GmbH, Clopidogrel, Peripheral Vascular Diseases,Acute Coronary Syndrome,Myocardial Infarction,Stroke, Date of Authorisation: 28/07/2009, Revision: 11, Status: Authorised

Case Medical Research
doi 10.31525/cmr-15997e4
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Case Journals

Related search

Human Medicines European Public Assessment Report (EPAR): DuoPlavin, Clopidogrel / Acetylsalicylic Acid, Acute Coronary Syndrome,Myocardial Infarction, Date of Authorisation: 14/03/2010, Revision: 18, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Brilique, Ticagrelor, Peripheral Vascular Diseases,Acute Coronary Syndrome, Date of Authorisation: 03/12/2010, Revision: 12, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Instanyl, Fentanyl, Pain,Cancer, Date of Authorisation: 20/07/2009, Revision: 21, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Prasugrel Mylan, Prasugrel, Myocardial Infarction,Acute Coronary Syndrome,Angina, Unstable, Date of Authorisation: 15/05/2018, Revision: 3, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Olazax, Olanzapine, Schizophrenia,Bipolar Disorder, Date of Authorisation: 11/12/2009, Revision: 10, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Farydak, Panobinostat, Multiple Myeloma, Date of Authorisation: 28/08/2015, Revision: 6, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Intelence, Etravirine, HIV Infections, Date of Authorisation: 28/08/2008, Revision: 23, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Lenvima, Lenvatinib, Thyroid Neoplasms, Date of Authorisation: 28/05/2015, Revision: 6, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Atosiban SUN, Atosiban, Premature Birth, Date of Authorisation: 31/07/2013, Revision: 6, Status: Authorised

Case Medical Research
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy